Chemomab Therapeutics Ltd. Quarterly Current Ratio in % from Q3 2020 to Q2 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Chemomab Therapeutics Ltd. quarterly Current Ratio history and growth rate from Q3 2020 to Q2 2023.
  • Chemomab Therapeutics Ltd. Current Ratio for the quarter ending June 30, 2023 was 583 %, a 70.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 583 -1.41K -70.7% Jun 30, 2023
Q1 2023 758 -1.82K -70.6% Mar 31, 2023
Q4 2022 1.02K -1.3K -56.2% Dec 31, 2022
Q3 2022 1.41K -710 -33.5% Sep 30, 2022
Q2 2022 1.99K +569 +40% Jun 30, 2022
Q1 2022 2.58K +1.69K +191% Mar 31, 2022
Q4 2021 2.32K +1.83K +369% Dec 31, 2021
Q3 2021 2.12K +1.69K +392% Sep 30, 2021
Q2 2021 1.42K Jun 30, 2021
Q1 2021 887 Mar 31, 2021
Q4 2020 494 Dec 31, 2020
Q3 2020 430 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.